Stanford University
Showing 1,161-1,180 of 1,809 Results
-
Jonathan D. Gortat
Director for Licensing and Strategic Alliances, Office of Technology Licensing (OTL)
BioJonathan Gortat is the Director of Licensing and Strategic Alliances at Stanford University's Office of Technology Licensing with more than 15 years experience in technology transfer. Prior to joining Stanford, he was assistant director at the University of Illinois-Chicago Office of Technology Management and in various roles at Purdue Research Foundation in technology transfer and working on a pre-seed investment fund. In addition, he has more than 5 years industrial pharmacy research and project management experience. He has extensive experience in pharmaceutical and chemical unit operations and analytical methods associated with the pharmaceutical industry. He holds an MBA from the Krannert Graduate School of Management at Purdue University and a baccalaureate of science degree in Chemical Engineering from Purdue University.
-
Heather Gotham
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Gotham’s research focuses on implementation science, including factors affecting implementation, and training and education of health care providers, across a range of evidence-based practices for adolescent and adult substance use and mental health disorders, co-occurring mental health and substance use disorders, and screening, brief intervention, and referral to treatment (SBIRT).
-
Ian Gotlib
Marjorie Mhoon Fair Professor
Current Research and Scholarly InterestsCurrent interests include social, cognitive, and biological factors in affective disorders; neural and cognitive processing of emotional stimuli and reward by depressed persons; behavioral activation and anhedonia in depression; social, emotional, and biological risk factors for depression in children.
-
Jason Gotlib
Professor of Medicine (Hematology)
Current Research and Scholarly InterestsMy research interests include phase I/II clinical trial evaluation of novel therapies for the following diseases:
--Myelodysplastic syndromes (MDS)
--Chronic myelogenous leukemia (CML)
--Acute myelogenous leukemia (AML)
--Myeloproliferative disorders (MPDs) including:
Hypereosinophilic syndrome
Systemic mastocytosis
BCR-ABL-negative MPDs -
Ryunosuke (Ryan) Goto
Ph.D. Student in Biomedical Data Science, admitted Autumn 2024
BioRyunosuke (Ryan) Goto is a PhD student in Biomedical Data Science and a Knight-Hennessy Scholar. Prior to Stanford, Ryan was a Chief Resident in Pediatrics at Nagano Children's Hospital and the University of Tokyo Hospital. He is working with Prof. Robert Tibshirani and Prof. Jonathan K. Pritchard to develop and apply statistical tools to investigate gene regulatory networks in human traits. Ryan’s work has been published in The Lancet, JAMA Pediatrics, and Pediatrics, among other journals.
